A dynamic in vitro model of Down Syndrome neurogenesis with Trisomy 21 gene dosage correction
Prakhar Bansal, Erin C. Banda, Heather R. Glatt-Deeley…·Stefan F. Pinter
This study uses a dynamic in vitro model to correct Trisomy 21 gene dosage in DS neurogenesis and shows XIST can suppress chr21 genes even after terminal differentiation.